ADC Bioconjugation
Case study
![](https://ewec85ye45b.exactdn.com/uploads/2023/09/DP5R2883_%40DavidPiole.jpg?strip=all&lossy=1&webp=80&ssl=1)
Development and cGMP manufacturing of a Phase I clinical candidate
![](https://ewec85ye45b.exactdn.com/uploads/2024/04/Case-study-ADC-Bioconjugation-visual-1.png?strip=all&lossy=1&webp=80&resize=305%2C432&ssl=1)
Axplora is an expert in ADCs with over 15 years’ experience and more than 200 clinical and commercial cGMP batches produced. We have a multi-scale bioconjugation manufacturing capacity with short-term availability and a fast-track bioconjugation services with seamless transition to clinical supply.
A clinical-stage biopharmaceutical company asked Axplora’s Le Mans site to perform the cGMP manufacture of an Antibody Drug Conjugate (ADC) for the treatment of solid tumors.
Highlights:
- Process and analytical development followed by cGMP manufacture of a phase I ADC
- Scale-up from gram to hundred-gram scale
- A robust process leading to 100% compliant batches